Abstract Probiotics play a vital role in clinical applications for the treatment of diarrhea, obesity and urinary tract infections. Phytate, an anti-nutrient, chelates essential minerals that are vital for human health. In the past few decades, research reports emphasize extensively on phytate degradation in animals. There is a growing need for finding alternate strategies of phytate utilization in human, as they are unable to produce phytase. At this juncture, probiotics can be utilized for phytase production to combat mineral deficiency in humans. The main focus of this review is on improving phosphate bioavailability by employing two approaches: supplementation of (1) fermented food products that contain probiotics and (2) recombinant phytase producing bacteria. In addition, several factors influencing phytase activity such as bacterial viability, optimal pH, substrate concentration and specificity were also discussed.
Introduction
The joint initiative of Food and Agricultural Organization (FAO) as well as the World Health Organization (WHO), defined probiotics as mono or mixed cultures of ''live microorganisms which when administered in adequate amounts beneficially affect the host'' [1] . The history of probiotics dates back to 1907 when Russian scientist Ellie Metchnikoff postulated the idea of using lactic acid bacteria for modulating intestinal flora. Since then intensive research was undertaken in the field of probiotics for improving human health and the timeline of these applications are presented in Fig. 1 .
Phytate also known as myo-inositol hexaphosphate is the principal storage form of phosphorus in plant-based foods.
The chemical structure of phytate consists of six phosphate groups (five of them present in equatorial position with the last one placed in axial position) attached to its inositol ring. The overall negative charge contributed by phosphates ( Fig. 2 ) help in chelating divalent and trivalent metal ions. Therefore, phytate acts as an anti-nutrient and limit mineral bioavailability in human. Despite causing a major nutritional deficiency, phytate can be regarded for its beneficial effects especially in treating colon cancer, AIDS, Alzheimer's disease, Arthritis and Parkinson's diseases [2] .
Phytases of plants and microorganisms degrade phytate into inositol and free orthophosphates. These enzymes differ in their structure. Plant-based phytases predominantly exist in alpha/beta form whereas, bacterial phytases belong to the beta class of proteins [3] .
The crystal structure of bacterial phytase consists of antiparallel b-sheets (Fig. 3) . The active site of enzyme consists of ''catalytic'' (phosphate 1) and ''affinity'' (phosphate 2) binding sites. The two phosphates of the substrate (phytate) bind to these sites causing structural conformations via both ionic and hydrogen bonding. Then the catalytic site is activated by three Ca 2? ions, which are vital for substrate binding. Besides, three more Ca 2? bind to the affinity site that improves the substrate specificity and overall stability of the enzyme. Binding of phosphate ions also activates the presence of a seventh Ca 2? ion in the structure. Catalysis is initiated by an attack of hydroxide ion of water molecule on the first phosphate group, triggering its cleavage. Thereafter, every alternate phosphate is cleaved leading to the final product. Phytases cleave equatorial phosphate groups readily as compared to axial ones [4] . Probiotic bacteria can be efficiently utilized for phytate utilization as compared to their plant-based counterparts owing to the former's increased substrate specificity and catalytic efficiency [5] .
Humans have a monogastric digestive system which lacks sufficient phytase producing bacteria in their intestine for phytate utilization. This leads to a serious nutritional deficiency in the host. The undigested phytate from food passes into the soil and lead to environmental phosphate pollution [2] . Hence, this review is focused on probiotic bacteria which are capable of degrading phytate in humans.
Probiotic Selection Criteria
Probiotics have been used for centuries due to their broad spectrum of biological activities in human. For bacteria to be used as probiotics, they must be nonpathogenic, non-invasive, non-carcinogenic, adhere to intestinal epithelium, resistant to gastric acidity, stable in food matrix during intestinal digestion, aid in immunomodulation, and colonize for a stable time period. Moreover, they must have verified strain properties, be effective against the specified target and exhibit bile salt hydrolase activity [6] .
These probiotics can be administered through enteral route or by enema. Enteral route is widely preferred for consumption of fermented food products. Whereas, an enema is preferred for fecal microbiota transplantation (FMT) [7] . The review is focused only on fermented food products for administering probiotics via an enteral route as it is cost-effective and convenient when compared to FMT [8, 9] . The choice of fermented foods that contain viable bacteria, which are capable of degrading phytate are listed in Table 1 .
Probiotic bacteria in fermented food products have an impact on human health. Probiotics isolated from a wide variety of functional foods ranging from sourdough to fermented bread, dairy products are capable of effective phytate degradation thereby aiding in improved mineral uptake in humans.
In general, probiotics competitively bind to the host intestinal epithelium and stimulate an immune response by activating specific signaling cascades and cell-based reactions. Each bacterial genera has a unique action mechanism for the corresponding biological functions.
Probiotics belonging to Bacilli group are gram-positive, facultative aerobes which produce non-pathogenic spores. The spores play an important role in increased shelf-life of the probiotic product as they are thermostable, recalcitrant to a wide range of pH fluctuations and viable under extreme intestinal conditions. The presence of an outer thick peptidoglycan layer protects bacterial spores from extreme heat, organic acids, lysosomal degradation and helps them in several beneficial activities on human health including treatment of rheumatoid arthritis and blood clotting.
Escherichia coli are gram-negative probiotic microbes which predominately participate in anti-inflammatory activity through modulation of the host immune system. They are also helpful in treatment of colitis and constipation.
Microbes belonging to genera Lactobacilli, Enterococci, Bifidobacteria, Pediococcus and Leuconostoc represents a group of non-pathogenic, facultative anaerobes which are commonly present in the human gut. In addition to their gastric viability, they efficiently colonize and have prolonged epithelial adherence. They also produce bacteriocins which competitively inhibit other pathogenic bacteria and maintain a healthy balance of beneficial microbes. These bacteria find applications ranging from preparation of fermented food products to clinical therapeutics such as inflammatory bowel disease (IBD), diarrhea, and cholesterol regulation.
Functional Foods for Phytase Production
Fermented foods like cheese, sausages and caper berry contain viable lactic acid producing bacteria that colonizes in the human intestine. In addition, it enables the sustenance of enzyme source and stability by continuous multiplication. Probiotic bacteria from fermented foods recorded high phytate degradation (Table S-1, see supplementary material). Fermented soybean containing Bacillus subtilis produced phytase activities ranging up to 1,354,906.6 U/mL.
Lower phytase, phosphatase activities were recorded for Lactobacilli sp. grown in sweet potato base medium (SPM) with sodium phytate, p-nitrophenyl phosphate as substrate. Lactobacillus casei 1 K produced highest phosphatase activity of 162,119.2 U/mL with 0.48% phytate hydrolysis.
The level of phytase activity in vivo depends on factors like; the concentration of phytate, bacterial viability, optimum pH, the accessibility of phytate, presence of inorganic phosphate and other organic acids. Human intestine normally maintains a constant temperature of 37°C with pH ranging from 5 to 7. Probiotic bacteria isolated from humans showed efficient phytate degradation (Table S-2,  see supplementary material) .
Bifidobacterium sp. BIF longum 12R, catenulatum 31S and breve 211 were isolated from human infants and adults after consumption of whole wheat bread. They produced high specific phytase activities of 6.92, 6.59 and 6.57 U/mg at pH 7.2. L. reuteri CECT 9025 produced the highest phosphatase activity in modified MRS medium containing sodium phytate.
In addition to above-mentioned parameters, molecular mass of phytase, substrate specificity and the presence of minerals also influence phytate degradation in the human intestine.
Microbial phytases may be monomeric or dimeric depending on the conformational state of the enzyme. The characteristics of phytases and phosphatases from probiotic bacteria are tabulated (Table 2) , where most of them contain monomeric chains. The exception being L. brevis, which has dimeric chains each with different molecular masses 73 and 34 kDa, respectively. Phosphorylated compounds are generated during digestion of food, mineral metabolism and their presence in the intestinal cavity may interfere with phytate degradation. Most of the bacterial phytases are highly specific towards sodium phytate.
Functional foods contain a good amount of trace elements and minerals important for human nutrition. These metal ions in different concentrations might affect probiotic phytate degradation. The effect of different minerals on phytase activity are tabulated ( 
Role of Recombinant Phytases and Their Expression
Oral consumption of fermented food products and FMT are effective strategies for probiotic delivery. However, these strategies are associated with certain disadvantages including lack of site specific action and short-term efficacy. This may be overcome by recombinant phytases (Table 4) . L. plantarum DPC2739, L. plantarum W723 Dairy products, Sorghum-Ogi [37, 38] Probiotics belonging to Bacilli genera are efficiently utilized for expression of cloned phytases. Phytase from B. licheniformis, when expressed in E. coli efficiently degraded phytate producing a phytase activity of 0.96 U/mL with a recombinant protein having a molecular mass of 66 kDa.
Lactic acid bacteria (LAB) can be effectively used for recombinant phytase expression [44] . They are safe, costeffective and also yield enzyme with high purity and stability. On the contrary, high species diversity, obscurity in the route of administration, and stringent monitoring due to lack of clinical trial data pose critical challenges in employing these recombinant probiotic phytases [45] .
Well-known probiotics belonging to genus Bacilli and Lactobacilli are capable of adherence and colonization in the human intestine. Most often they are inferred by their high cell counts. They produce bacteriocins, which competitively inhibit pathogens thereby aiding overall improvement of gut microbiome. Moreover, consumption of fermented foods containing viable bacteria provides a scope for phytate degradation.
Conclusion and Future Scope
Phytases from probiotics provide a solution for phosphate utilization in humans. This can be achieved by consuming fermented food products, an ideal vehicle for delivering probiotics. It was noted that L. brevis and B. subtilis in fermented food products are capable of producing higher amount of phytase. Most of the probiotic phytases are very specific towards phytate and are stimulated by Ca 2? ions for effective activity. Alternatively, recombinant phytases can also be used for intestinal phytate utilization. Despite the wide usage of probiotics, it is yet to be approved by US Food and Drug Administration (FDA). Therefore, more research needs [33]
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Fluoride, hexametaphosphate at 0.5 mM and orthophosphate, tripolyphosphate and pyrophosphate at 5 mM (phosphatase) [37] to be done on improvising probiotic strains for phytase production as well as optimizing probiotic dosage for phytate utilization.
